Advertisement

Topics

Transposagen Biopharmaceuticals, Inc. Company Profile

12:26 EDT 26th September 2017 | BioPortfolio

Transposagen Biopharmaceuticals, Inc., a Lexington, KY based company, is the worldwide leader in the creation of unique genetically modified rat models. The company's signature products, TKO(TM) Knockout Rat Models and TGEM(TM) Rat Models, mimic human diseases and are used for drug discovery and development research. The company also creates custom transgenic rat models to customer specifications. The production of animal models is a $1.2 billion/year market and is expected to grow 12% annually through 2012. For more information, visit www.transposagenbio.com.


News Articles [126 Associated News Articles listed on BioPortfolio]

Critical Analysis: Keryx Biopharmaceuticals (KERX) vs. Its Peers

Keryx Biopharmaceuticals is one of 288 public companies in the "Bio Therapeutic Drugs" industry, but how does it weigh in compared to its rivals? We will compare Keryx Biopharmaceuticals to related co...

Alder BioPharmaceuticals (ALDR) versus Raptor Pharmaceutical Corp (RPTP) Head to Head Comparison

Alder BioPharmaceuticals and Raptor Pharmaceutical Corp are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recomm...

Innovate Biopharmaceuticals's Pediatric Ulcerative Colitis Drug Granted Innovate Biopharmaceuticals Orphan Designation

  Life Sciences Jobs   ...

Sienna Biopharmaceuticals nets $60mm in Nasdaq IPO

Aesthetics- and dermatology-focused Sienna Biopharmaceuticals Inc. (targeted topical delivery technology) netted $60mm through an initial public offering of 4.33mm shares at $15, the midpoint of its a...

'Small intestinal permeable peptides' improve biopharmaceuticals absorption in digestive tract

Biopharmaceuticals, medium- and high-molecular weight biologically active macromolecules, are not easily absorbed by the small intestine, the main organ responsible for gastrointestinal absorption, re...

Keryx Biopharmaceuticals, Inc. (KERX) Downgraded by ValuEngine

Several other research firms have also commented on KERX. Zacks Investment Research upgraded Keryx Biopharmaceuticals from a hold rating to a buy rating and set a $8.75 price objective for the company...

Keryx Biopharmaceuticals, Inc. (KERX) Shares Up 5.4%

Keryx Biopharmaceuticals, Inc. shares shot up 5.4% during mid-day trading on Friday . The company traded as high as $7.68 and last traded at $7.60, with a volume of 1,238,961 shares trading hands.

Monster Digital and Innovate Biopharmaceuticals reverse merge

Non-medical firm Monster Digital Inc. and gastrointestinal disease-focused Innovate Biopharmaceuticals Inc. agreed to reverse merge in a stock swap.

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

PubMed Articles [49 Associated PubMed Articles listed on BioPortfolio]

Current practice of therapeutic drug monitoring of biopharmaceuticals in psoriasis patients.

The high prevalence of psoriasis and the high spending on pharmaceuticals motivate a more evidence-based and cost-effective usage of biopharmaceuticals. A growing body of evidence exists that the impl...

Biopharmaceuticals: reference products and biosimilars to treat inflammatory diseases.

Biopharmaceuticals are primarily therapeutic proteins developed to perform specific functions by acting on the disease pathophysiology. Compared to low molecular chemically synthesized drugs, producti...

Current practice of therapeutic drug monitoring of biopharmaceuticals in spondyloarthritis.

Treatment of spondyloarthritis (SpA) has greatly improved in the biopharmaceutical era. These compounds, primarily tumor necrosis factor (TNF) inhibitors, are effective, but some patients may show poo...

Immunoassays for measuring serum concentrations of monoclonal antibodies and anti-biopharmaceutical antibodies in patients.

Monoclonal antibodies (mAbs) may be used as biopharmaceuticals to treat various diseases, ranging from oncology to inflammatory and cardiovascular affections. Trustworthy analytical methods are necess...

Current practice for therapeutic drug monitoring of biopharmaceuticals in inflammatory bowel disease.

Since the late nineties, biopharmaceuticals targeting tumor necrosis factor α have revolutionized the treatment of moderately to severely active inflammatory bowel disease. The robust efficacy witnes...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Companies [183 Associated Companies listed on BioPortfolio]

Transposagen Biopharmaceuticals, Inc.

Transposagen Biopharmaceuticals, Inc., a Lexington, KY based company, is the worldwide leader in the creation of unique genetically modified rat models. The company's signature products, TKO(TM) Knoc...

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treat...

More Information about "Transposagen Biopharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Transposagen Biopharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Transposagen Biopharmaceuticals, Inc. Clinical Trials and PubMed Articles about Transposagen Biopharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Transposagen Biopharmaceuticals, Inc. Companies in our database. You can also find out about relevant Transposagen Biopharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record